Advertisement

Topics

REPLACE: Implantable Cardiac Pulse Generator Replacement Registry

2014-08-27 03:41:45 | BioPortfolio

Summary

The objective of this study is to prospectively estimate the all-cause complication rates at 6-months for patients undergoing generator replacement due to elective replacement indicator (ERI), advisory, or upgrade without a planned system modification or with a planned system modification. Secondarily, this study aims to compare the influence of baseline variables contributing to the all-cause complication rates for subjects undergoing generator replacement.

Description

Device replacements occur for many reasons, including elective replacement indication (ERI), manufacturer advisory, and upgrade.

Recently pacemaker and implantable cardioverter (ICD) advisories have created a dilemma for both physicians and patients. While the risk of device malfunction is low, replacement rates following an advisory are usually high and complication rates following device replacement are not widely known. One retrospective analysis of ICD advisories in Canada reported an 18.3% replacement rate, and subsequent 8.1% complication rate directly related to the replacement.

Device replacements also occur in order to upgrade an existing system. Clinical studies have shown that cardiac resynchronization therapy (CRT) significantly reduces all-cause mortality and hospitalization in patients with advanced heart failure (HF). As a result of expanding indications for this therapy, many standard ICD patients are being upgraded to CRT-D systems. Complication rates related to upgrades of these systems are also not widely known.

To our knowledge, the risk of complications following a device replacement has not been studied prospectively in any patient population. Limited data are available to guide physicians when weighing the risks and benefits of device replacement.

This is a prospective multi-center study. 1750 patients at 100 clinical sites will be enrolled prior to generator replacement. Patients will be implanted and followed for 6 months to assess any complications related to the replacement procedure.

Patients with any legally marketed device for explant can be enrolled. The replacement device can be from any manufacturer.

Study Design

Allocation: Non-Randomized, Control: Uncontrolled, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Conditions

Device Replacement

Intervention

Pulse generator replacement or upgrade, Pacemaker, ICD or CRT system

Location

University of Alabama at Birmingham
Birmingham
Alabama
United States
35294

Status

Completed

Source

Biotronik, Inc.

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:41:45-0400

Clinical Trials [3295 Associated Clinical Trials listed on BioPortfolio]

DEtect Long-term Complications After icD rEplacement: a Multicenter Italian Registry

This study has been designed to prospectively estimate long term complication rates (12-months and 5-years) in patients undergoing Implantable Cardioverter Defibrillator (ICD) replacement,...

Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty

To evaluate effectiveness and safety of the HIT Hip Replacement System (HHRS) in patients undergoing total hip arthroplasty (THA). Effectiveness will be evaluated using patient-reported, c...

A Multicenter Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System Versus Off-the-Shelf Replacement

Patients will be randomized to either ConforMIS iTotal Knee Replacement or Off the Shelf knee replacement. The patient will conduct functional testing and answer questionnaires. Th...

Ceramic on Metal Total Hip Replacement System Multi-Center,Investigational Device Exemption Clinical Trial

The purpose of this study is to demonstrate non-inferiority of the Ceramic on Metal Total Hip when compared to a TRANSCEND® historical control group of patients with primary total hip rep...

PREFER (Pacemaker Remote Follow-Up Evaluation and Review)

The purpose of this study is to compare remote pacemaker follow-up to current standard of care follow-up. The study will compare the rate of first diagnosis of clinically actionable events...

PubMed Articles [12384 Associated PubMed Articles listed on BioPortfolio]

Impact of pacemaker longevity on expected device replacement rates: results from computer simulations based on a Multicenter Registry (ESSENTIAL).

We estimated the probability of device replacement in an unselected population of pacemaker recipients, with automatic management of atrial and ventricular pacing output.

A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study.

Historically, providing SNM therapy required use of a non-rechargeable implantable pulse generator (IPG) with an average device lifespan of 4.4 years. Multiple device replacement surgeries are necessa...

Outcomes Following Implantable Cardioverter-Defibrillator Generator Replacement in Patients with Recovered Left Ventricular Systolic Function: the National Cardiovascular Data Registry.

Some patients with heart failure (HF) experience recovery of left ventricular (LV) systolic function by the end of their ICD generator battery-life. Outcomes following generator replacement in this se...

Association of Clinical and Economic Outcomes With Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement.

The literature is inconsistent regarding the impact of permanent pacemaker implantation after transcatheter aortic valve replacement.

Pacemaker system replacement under local anesthesia allowing MRI access 7 years after the initial surgery: Two case reports.

Older pacemaker systems, which are magnetic resonance imaging (MRI) incompatible, require replacement with compatible systems when patients are in need of MRI. Replacement involves extraction of the p...

Medical and Biotech [MESH] Definitions

Therapeutic replacement or supplementation of defective or missing enzymes to alleviate the effects of the enzyme deficiency (e.g., GLUCOSYLCERAMIDASE replacement for GAUCHER DISEASE).

Partial or total replacement of a joint.

Replacement of the hip joint.

Partial or total replacement of one or more FINGERS, or a FINGER JOINT.

Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed)

More From BioPortfolio on "REPLACE: Implantable Cardiac Pulse Generator Replacement Registry"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Searches Linking to this Trial